<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
  <url>
    <loc>https://www.raremoonconsulting.com/</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>weekly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/about-us</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/expertise</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/contact</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/orphan-drug-designations</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/services/breakthrough-therapy</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/services/rmat</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/services/ema-advice</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/regulatory-designations</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/regulatory-filings</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/services/regulatory-writing</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/regulatory-operations-publishing</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/health-agency-meetings</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/fractional-regulatory-services</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/rare-pediatric-designation</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/priority-review-voucher-programs</loc>
    <lastmod>2026-03-29</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/odd-approvals-strong-trend</loc>
    <lastmod>2026-04-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/layering-fda-rare-disease-programs</loc>
    <lastmod>2026-04-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/plausible-mechanism-rdep</loc>
    <lastmod>2026-04-24</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/crls-and-what-we-are-watching</loc>
    <lastmod>2026-03-25</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/fda-designation-action-plan</loc>
    <lastmod>2026-03-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/10-year-anniversary</loc>
    <lastmod>2026-02-02</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/jpm-2026</loc>
    <lastmod>2025-12-16</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/ask-the-expert-sarah-disalvatore</loc>
    <lastmod>2025-12-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/ask-the-expert-kaye-spratt</loc>
    <lastmod>2025-11-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/orphan-insights-part-1</loc>
    <lastmod>2025-11-10</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/clinical-holds-collaboration</loc>
    <lastmod>2025-06-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/fda-cnpv-pilot-program</loc>
    <lastmod>2025-06-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/fda-rdep-process</loc>
    <lastmod>2025-06-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/dr-vinay-prasad</loc>
    <lastmod>2025-06-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/fda-staffing-challenges</loc>
    <lastmod>2025-06-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/hope-horizon-mps-iiia</loc>
    <lastmod>2025-06-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/keeping-pace-with-innovation</loc>
    <lastmod>2025-06-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/navigating-fda-orphan-drug-designation</loc>
    <lastmod>2025-06-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/raremoon-expert-pip-training</loc>
    <lastmod>2025-06-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/rpd-prv-program-renewal</loc>
    <lastmod>2025-06-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/stay-the-course</loc>
    <lastmod>2025-06-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/why-we-exist</loc>
    <lastmod>2025-06-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/ask-the-expert-lilia-bi</loc>
    <lastmod>2025-06-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.raremoonconsulting.com/insights/ask-the-expert-mette-thomsen</loc>
    <lastmod>2025-06-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
</urlset>